Literature DB >> 17313201

Evolution of medication use in Jerusalem elders: Results from the Jerusalem Longitudinal Study.

Michael A Steinman1, Yoram Maaravi, Louise C Walter, Robert Hammerman-Rozenberg, Jochanan Stessman.   

Abstract

BACKGROUND: While overall rates of medication use have been increasing over time, less is known about how medication use changes within individuals as they age.
OBJECTIVE: The aim of this study was to evaluate changes in medication use and predictors of medication accrual among community-dwelling elders followed for a 7-year period, from age 70 +/- 1 years to age 77 +/- 1 years.
METHODS: The study was a community-based, longitudinal, cohort study. The study group consisted of 280 patients from the Jerusalem Longitudinal Study, a population-based sample of Jerusalem residents born in 1920-1 who underwent extensive evaluation in 1990-1 and again in 1997-8. The main outcome measure of the study was the change in the total number of medications taken between baseline and follow-up. Medication use was assessed by home interviews.
RESULTS: Half of the sample were men. Medication use more than doubled over the 7-year study period, from a mean of 2.0 to 5.3 medications per patient (p < 0.001), and 57 patients (20%) increased their total drug use by six or more medications. Vitamins, minerals and cardiovascular medications were the most commonly prescribed medications at follow-up, and accounted for approximately half of the total increase in medication use. On multivariable logistic regression analyses, decline in self-rated health was the strongest predictor of above-median increases in medication use (odds ratio [OR] 3.2; 95% CI 1.8, 6.2). The only nonclinical predictor of above-median increases in medication use was good social engagement at baseline (OR 1.8; 95% CI 1.1, 3.1).
CONCLUSION: Medication use in Jerusalem elders grew rapidly over the 1990s, more than doubling in volume over a 7-year period. While health status was the factor most strongly predictive of the degree of change, the magnitude of increase for elders as a whole suggests major changes in prescribing practices over this interval.

Entities:  

Mesh:

Year:  2007        PMID: 17313201     DOI: 10.2165/00002512-200724020-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  31 in total

1.  Recent trends in drug utilization in Israel.

Authors:  P Sax
Journal:  Isr J Med Sci       Date:  1992-10

Review 2.  Polypharmacy: a new paradigm for quality drug therapy in the elderly?

Authors:  Jerry H Gurwitz
Journal:  Arch Intern Med       Date:  2004-10-11

3.  Inequalities in the treatment and control of hypertension: age, social isolation and lifestyle are more important than economic circumstances.

Authors:  S Shah; D G Cook
Journal:  J Hypertens       Date:  2001-07       Impact factor: 4.844

Review 4.  Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine.

Authors:  M H Beers; J G Ouslander; I Rollingher; D B Reuben; J Brooks; J C Beck
Journal:  Arch Intern Med       Date:  1991-09

5.  Profile of Jerusalem's 70 year olds--medical data.

Authors:  J Stessman; G Ginsberg; Y Maaravi; R Hammerman-Rozenberg; A Cohen
Journal:  Isr J Med Sci       Date:  1996-08

6.  Expenditure and consumption of medicines in Israel 1975-85: analysis of trends and elements of growth.

Authors:  P Sax
Journal:  Isr J Med Sci       Date:  1988-06

7.  Spending on medicines in Israel in an international context.

Authors:  Philip Sax
Journal:  Isr Med Assoc J       Date:  2005-05       Impact factor: 0.892

8.  The development of polypharmacy. A longitudinal study.

Authors:  L Veehof; R Stewart; F Haaijer-Ruskamp; B M Jong
Journal:  Fam Pract       Date:  2000-06       Impact factor: 2.267

9.  Patterns of drug use among the community-dwelling old-old population in Israel.

Authors:  Zahava Fuchs; Ilya Novikov; Tzvia Blumstein; Angela Chetrit; Jacob Gindin; Baruch Modan
Journal:  Isr Med Assoc J       Date:  2003-05       Impact factor: 0.892

10.  Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly.

Authors:  E A Chrischilles; D J Foley; R B Wallace; J H Lemke; T P Semla; J T Hanlon; R J Glynn; A M Ostfeld; J M Guralnik
Journal:  J Gerontol       Date:  1992-09
View more
  1 in total

1.  Determinants and consequences of polypharmacy in patients with a depressive disorder in later life.

Authors:  Carlijn Wiersema; Richard C Oude Voshaar; Rob H S van den Brink; Hans Wouters; Peter Verhaak; Hannie C Comijs; Hans W Jeuring
Journal:  Acta Psychiatr Scand       Date:  2022-04-29       Impact factor: 7.734

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.